The Adalimumab Injection, cataloged under National Stock Number 6505-01-691-4533, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Abbvie Us Llc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: EA.
| Parameter | Value |
|---|---|
| NSN | 6505-01-691-4533 |
| Primary Part Number | NDC00074-4339-02 |
| Item Name | Adalimumab Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Abbvie Us Llc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | EA |
| Part Number | Manufacturer |
|---|---|
| NDC00074-4339-02 PRIMARY | Abbvie Us Llc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM206473 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1582722 | 5/1 Secondary reference U.S. Government activity |
| HUMIRA | 5/1 Secondary reference Abbvie Us Llc |
NSN 6505-01-691-4533 is a Adalimumab Injection, manufactured by Abbvie Us Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-691-4533 has 1 manufacturer part number on file: NDC00074-4339-02 (Abbvie Us Llc).
Key specifications for NDC00074-4339-02: Special Features: HUMIRA IS A TISSUE NECROSIS FACTOR (TNF) BLOCKER INDICATED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS TO REDUCE THE SIGNS AND SYMPTOMS INDUCING MAJOR CLINICAL RESPONSE, INHIBITING THE PROGRESSION OF STRUCTURAL DAMAGE, AND IMPROVING PHYSICAL FUNCTION IN ADULT PATIENTS; HUMIRA IS SUPPLIED IN A CARTON CONTAINING A 1 ML PREFILLED GLASS SYRINGE WITH A FIXED 1/2 INCH NEEDLE, PROVIDING 40 MG/0.8 ML OF HUMIRA; THE NEEDLE COVER MAY CONTAIN NATURAL RUBBER LATEX; INTENDED FOR SUBCUTANEOUS ADMINISTRATION; DO NOT USE BEYOND THE EXPIRATION DATE ON THE CONTAINER; HUMIRA MUST BE REFRIGERATED AT 36 F TO 46 F (2 C TO 8 C); DO NOT FREEZE; DO NOT USE IF FROZEN EVEN IF IT HAS BEEN THAWED. IN; Part Name Assigned by Controlling Agency: ADALIMUMAB INJECTION, 40 MG/0.8 ML. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.